Evidence map›Paper›PMID 26436601›Full record

SynthesisThe Cochrane database of systematic reviews2015

Oral nonsteroidal anti-inflammatory drugs for neuropathic pain.

R Andrew Moore, Ching-Chi Chi, Philip J Wiffen, Sheena Derry, Andrew S C Rice

Registry-linked trialOpen access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07393139 (Early Postoperative Pain and Functional Recovery Following a Limb Amputation), which is not on this map. Cited by 71 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 13 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07393139 recruitingnot on this mapstarted 2026, after this paper: background citation

Early Postoperative Pain and Functional Recovery Following a Limb Amputation: a Retrospective Observational Study.

TypeobservationalSponsorIstituto Ortopedico RizzoliRan2026 to 2026Enrolled150ConditionsAmputation, Surgical, Pain Management, RehabilitationArmsPain assessment
3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 13 syntheses or guidelines pooled it, 132 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pregabalin for neuropathic pain in adults.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Pooled it
  5. Cannabis-based medicines for chronic neuropathic pain in adults.The Cochrane database of systematic reviews · 2018
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Drug therapy for chronic idiopathic axonal polyneuropathy.The Cochrane database of systematic reviews · 2017
    Pooled it
  10. Tramadol for neuropathic pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  11. Gabapentin for chronic neuropathic pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  12. Morphine for chronic neuropathic pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  13. Methadone for neuropathic pain in adults.The Cochrane database of systematic reviews · 2017
    Pooled it
  14. Trial
  15. Trial
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

R Andrew MoorePain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics), University of Oxford, Pain Research Unit, Churchill Hospital, Oxford, Oxfordshire, UK, OX3 7LE.
Ching-Chi Chi
Philip J Wiffen
Sheena Derry
Andrew S C Rice
Chang Gung University · TWImperial College London · GBThame Community Hospital · GB

Funding

Department of Health 13/89/29
6 · The paper itself

Abstract

backgroundAlthough often considered to be lacking adequate evidence, nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used in the management of neuropathic pain. Previous surveys found 18% to 47% of affected people reported using NSAIDs specifically for their neuropathic pain, although possibly not in the United Kingdom (UK).

objectivesTo assess the analgesic efficacy of oral NSAIDs for chronic neuropathic pain in adults, when compared to placebo or another active intervention, and the adverse events associated with its use in clinical trials. SEARCH

methodsWe searched CENTRAL, MEDLINE, and EMBASE from inception to 29 May 2015, together with reference lists of retrieved papers and reviews, and an online trials registry. SELECTION CRITERIA: We included randomised, double-blind studies of two weeks duration or longer, comparing any oral NSAID with placebo or another active treatment in chronic neuropathic pain. DATA COLLECTION AND ANALYSIS: Two review authors independently searched for studies, extracted efficacy and adverse event data, and examined issues of study quality. We did not carry out any pooled analysis. MAIN

resultsWe included two studies involving 251 participants with chronic low back pain with a neuropathic component or postherpetic neuralgia; 209 of these participants were involved in a study of an experimental NSAID not used in clinical practice, and of the remaining 42, only 16 had neuropathic pain. This represented only third tier evidence, and was of very low quality. There was no indication of any significant pain reduction with NSAIDs. Adverse event rates were low, with insufficient events for any analysis. AUTHORS'

conclusionsThere is no evidence to support or refute the use of oral NSAIDs to treat neuropathic pain conditions.

Indexed as

Administration, OralAdultAnti-Inflammatory Agents, Non-SteroidalBack PainCelecoxibHumansNeuralgiaNeuralgia, PostherpeticPregabalinPyrazolesPyridazinesRandomized Controlled Trials as TopicAnti-Inflammatory Agents, Non-SteroidalCelecoxibGW406381XPregabalinPyrazolesPyridazines

Identifiers

PMID26436601
PMCPMC6481590
OpenAlexW1926546914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.